RAGE, Human, ELISA Kit, Quantikine (96 well)

データシート※最新のデータシートでない場合があります

• 商品コード：DRG00
• メーカー：RSD
• 包装：1kit
• 価格： ¥116,000
• 在庫：1個

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Falcone C et al. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler. Thromb. Vasc. Biol. 2005 May;25(5):1032-7
  Falcone C et al
  2005/01/01
  
• 備考：
  Sample Type: Plasma (EDTA)
• 参照：
  

• No.： 2
• 文献情報：
  Humpert PM et al. Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes. Diabetes Care 2006 May;29(5):1111-3
  Humpert PM et al
  2006/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 3
• 文献情報：
  Tan KC et al. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 2006 Nov;49(11):2756-62
  Tan KC et al
  2006/01/01
  
• 備考：
  Species: Human, Application: Serum
• 参照：
  

• No.： 4
• 文献情報：
  Gillette-Ferguson I et al. Toll-like receptor 2 regulates CXC chemokine production and neutrophil recruitment to the cornea in Onchocerca volvulus/Wolbachia-induced keratitis. Infect. Immun. 2007 Dec;75(12):5908-15
  Gillette-Ferguson I et al
  2007/01/01
  
• 備考：
  Species: Mouse, Sample type: Cell Supernates, Homogenized Tissue
• 参照：
  

• No.： 5
• 文献情報：
  Gross S et al. Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients. Transplantation 2007 Sep;84(5):659-63
  Gross S et al
  2007/01/01
  
• 備考：
  Species: Human, Sample type: Plasma (Not Specified)
• 参照：
  

• No.： 6
• 文献情報：
  Wittkowski H et al. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12. Arthritis Rheum. 2007 Dec;56(12):4174-81
  Wittkowski H et al
  2007/01/01
  
• 備考：
  Species: Human, Sample type: Serum
• 参照：
  

• No.： 7
• 文献情報：
  Rosas IO et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008 Apr;5(4):e93
  Rosas IO et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Plasma, Serum
• 参照：
  

• No.： 8
• 文献情報：
  Calfee CS et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008 Dec;63(12):1083-9
  Calfee CS et al
  2008/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 9
• 文献情報：
  Raucci A et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 2008 Oct;22(10):3716-27
  Raucci A et al
  2008/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 10
• 文献情報：
  H奪llstr旦m L et al. Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia. Crit. Care Med. 2008 Nov;36(11):3043-7
  H奪llstr旦m L et al
  2008/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 11
• 文献情報：
  Katakami N et al. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. Atherosclerosis 2009 May;204(1):288-92
  Katakami N et al
  2009/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 12
• 文献情報：
  Iłzecka J. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis. Acta Neurol. Scand. 2009 Aug;120(2):119-22
  Iłzecka J
  2009/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 13
• 文献情報：
  Yan XX et al. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis 2009 Aug;205(2):544-8
  Yan XX et al
  2009/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 14
• 文献情報：
  Kalea AZ et al. RAGE: a novel biological and genetic marker for vascular disease. Clin. Sci. 2009 Apr;116(8):621-37
  Kalea AZ et al
  2009/01/01
  
• 備考：
  Sample Type: N/A
• 参照：
  

• No.： 15
• 文献情報：
  Makam M et al. Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc. Natl. Acad. Sci. U.S.A. 2009 Apr;106(14):5779-83
  Makam M et al
  2009/01/01
  
• 備考：
  Sample Type: Plasma,Sputum
• 参照：
  

• No.： 16
• 文献情報：
  Mahajan N et al. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease. Atherosclerosis 2009 Dec;207(2):597-602
  Mahajan N et al
  2009/01/01
  
• 備考：
  Sample Type: Plasma (EDTA)
• 参照：
  

• No.： 17
• 文献情報：
  Buhimschi CS et al. Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. Am. J. Pathol. 2009 Sep;175(3):958-75
  Buhimschi CS et al
  2009/01/01
  
• 備考：
  Sample Type: Plasma (Heparin)
• 参照：
  

• No.： 18
• 文献情報：
  Bastarache JA et al. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am. J. Physiol. Lung Cell Mol. Physiol. 2009 Dec;297(6):L1035-41
  Bastarache JA et al
  2009/01/01
  
• 備考：
  Sample Type: Edema Fluid
• 参照：
  

• No.： 19
• 文献情報：
  Tam HL et al. Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes. Atherosclerosis 2010 Mar;209(1):173-7
  Tam HL et al
  2010/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 20
• 文献情報：
  Penfold SA et al. Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int. 2010 Aug;78(3):287-95
  Penfold SA et al
  2010/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 21
• 文献情報：
  Nin JW et al. Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes 2010 Aug;59(8):2027-32
  Nin JW et al
  2010/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 22
• 文献情報：
  Jabaudon M et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit. Care Med. 2011 Mar;39(3):480-8
  Jabaudon M et al
  2011/01/01
  
• 備考：
  Sample Type: Edema Fluid,Plasma (Not Specified)
• 参照：
  

• No.： 23
• 文献情報：
  Yamakawa N et al. Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2011 Apr;300(4):L516-25
  Yamakawa N et al
  2011/01/01
  
• 備考：
  Sample Type: pulmonary edema fluid
• 参照：
  

• No.： 24
• 文献情報：
  Colhoun HM et al. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial. Diabetes 2011 Sep;60(9):2379-
  Colhoun HM et al
  2011/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 25
• 文献情報：
  Narvaez-Rivera RM et al. Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis. BMC Infect. Dis. 2012;12:15
  Narvaez-Rivera RM et al
  2012/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 26
• 文献情報：
  Wittwer C et al. Methodological and preanalytical evaluation of a RAGE immunoassay. Anticancer Res. 2012 May;32(5):2075-8
  Wittwer C et al
  2012/01/01
  
• 備考：
  Sample Type: Plasma,Serum
• 参照：
  

• No.： 27
• 文献情報：
  Brix JM et al. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity. Int J Obes (Lond) 2012 Nov;36(11):1412-7
  Brix JM et al
  2012/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 28
• 文献情報：
  Campbell DJ et al. Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels. PLoS ONE 2012;7(11):e49813
  Campbell DJ et al
  2012/01/01
  
• 備考：
  Sample Type: Plasma
• 参照：
  

• No.： 29
• 文献情報：
  Zakiyanov O et al. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobi
  Zakiyanov O et al
  2013/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 30
• 文献情報：
  Hong S et al. Targeted gene silencing using a follicle-stimulating hormone peptide-conjugated nanoparticle system improves its specificity and efficacy in ovarian clear cell carcinoma in vitro. J Ovarian Res 2013;6(1):80
  Hong S et al
  2013/01/01
  
• 備考：
  Sample Type: Cell Culture Supernates
• 参照：
  

• No.： 31
• 文献情報：
  Wei W et al. GeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous expression in Chinese hamster ovary cells. Protein Expr. Purif. 2014 Mar;95:143-8
  Wei W et al
  2014/01/01
  
• 備考：
  Sample Type: Cell culture medium
• 参照：
  

• No.： 32
• 文献情報：
  Gopal P et al. Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD. Respir. Res. 2014;15:24
  Gopal P et al
  2014/01/01
  
• 備考：
  Sample Type: Blood
• 参照：
  

• No.： 33
• 文献情報：
  Momma H et al. Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study. Diabetol Metab Syndr 2014;6(1):33
  Momma H et al
  2014/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 34
• 文献情報：
  Chou CW et al. The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia. BMC Pulm Med 2014;14:182
  Chou CW et al
  2014/01/01
  
• 備考：
  Sample Type: BALF,Plasma
• 参照：
  

• No.： 35
• 文献情報：
  Jabaudon M et al. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study. PLoS ONE 2015;10(8):e0135857
  Jabaudon M et al
  2015/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 36
• 文献情報：
  Heier M et al. Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study. Cardiovasc Diabetol 2015;14(1):126
  Heier M et al
  2015/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 37
• 文献情報：
  Maruthur NM et al. Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study. PLoS ONE 2015;10(6):e0128452
  Maruthur NM et al
  2015/01/01
  
• 備考：
  Sample Type: Plasma
• 参照：
  

• No.： 38
• 文献情報：
  Lee AC et al. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes. PLoS ONE 2015;10(9):e0137330
  Lee AC et al
  2015/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 39
• 文献情報：
  Moser B et al. Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. PLoS ONE 2014;9(9):e106440
  Moser B et al
  2014/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 40
• 文献情報：
  Boraldi F et al. Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating Cells Involved in Endothelial Dysfunction. PLoS ONE 2016;11(8):e0160153
  Boraldi F et al
  2016/01/01
  
• 備考：
  Sample Type: Plasma
• 参照：
  

• No.： 41
• 文献情報：
  Negrin LL et al. Club cell protein 16 and cytokeratin fragment 21-1 as early predictors of pulmonary complications in polytraumatized patients with severe chest trauma. PLoS ONE 2017;12(4):e0175303
  Negrin LL et al
  2017/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 42
• 文献情報：
  Jabaudon M et al. Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study. Sci Rep 2018 Feb;8(1):2603
  Jabaudon M et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 43
• 文献情報：
  Paradela-Dobarro B et al. Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition. Cardiovasc Diabetol 2017 09;16(1):115
  Paradela-Dobarro B et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 44
• 文献情報：
  White DL et al. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med 2018 May;7(5):2180-2191
  White DL et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 45
• 文献情報：
  Zhu W et al. TGFβ1 reinforces arterial aging in the vascular smooth muscle cell through a long-range regulation of the cytoskeletal stiffness. Sci Rep 2018 Feb;8(1):2668
  Zhu W et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 46
• 文献情報：
  Popp CJ et al. The rationale and design of the personal diet study, a randomized clinical trial evaluating a personalized approach to weight loss in individuals with pre-diabetes and early-stage type 2 diabetes. Contemp Clin Trials 2019 Apr;79:80-88
  Popp CJ et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 47
• 文献情報：
  da Silva LF et al. Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status. PLoS ONE 2019;14(3):e0213991
  da Silva LF et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 48
• 文献情報：
  Abdulle A et al. Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of soluble RAGEs. J Clin Transl Endocrinol 2019 Jun;16:100192
  Abdulle A et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 49
• 文献情報：
  Klont F et al. Quantification of the soluble Receptor of Advanced Glycation End-Products (sRAGE) by LC-MS after enrichment by strong cation exchange (SCX) solid-phase extraction (SPE) at the protein level. Anal. Chim. Acta 2018 Dec;1043:45-51
  Klont F et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 50
• 文献情報：
  Maresca AM et al. sRAGE and early signs of cardiac target organ damage in mild hypertensives. Cardiovasc Diabetol 2019 02;18(1):17
  Maresca AM et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 51
• 文献情報：
  Tasca KI et al. The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected Individuals. Mediators Inflamm. 2016;2016:2909576
  Tasca KI et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 52
• 文献情報：
  Machahua C et al. Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis. Respir. Res. 2018 Nov;19(1):215
  Machahua C et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 53
• 文献情報：
  Chiang KH et al. The ratio of AGE to sRAGE independently associated with albuminuria in hypertensive patients. BMC Endocr Disord 2018 Nov;18(1):84
  Chiang KH et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 54
• 文献情報：
  Srinivasan L et al. Elevations of novel cytokines in bacterial meningitis in infants. PLoS ONE 2018;13(2):e0181449
  Srinivasan L et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 55
• 文献情報：
  Kumar NP et al. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy. BMC Infect Dis 2019 Dec;19(1):1039
  Kumar NP et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 56
• 文献情報：
  Ebert H et al. Advanced glycation end products and their ratio to soluble receptor are associated with limitations in physical functioning only in women: results from the CARLA cohort. BMC Geriatr 2019 11;19(1):299
  Ebert H et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 57
• 文献情報：
  Holte KB et al. Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study. PLoS One 2020;15(5):e0233174
  Holte KB et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 58
• 文献情報：
  Mendoza-N炭単ez VM et al. The Effect of 600 mg Alpha-lipoic Acid Supplementation on Oxidative Stress, Inflammation, and RAGE in Older Adults with Type 2 Diabetes Mellitus. Oxid Med Cell Longev 2019;2019:3276958
  Mendoza-N炭単ez VM et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 59
• 文献情報：
  Ebert H et al. Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study. Exp Gerontol 2020 03;131:110815
  Ebert H et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 60
• 文献情報：
  Gel転insk箪 J et al. Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness. Hypertens Res 2020 02;43(2):111-120
  Gel転insk箪 J et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 61
• 文献情報：
  Vinton CL et al. Biomarkers of Cellular Stress Do Not Associate with sCD14 in Progressive HIV and SIV Infections <i>in Vivo</i>. Pathog Immun 2020;5(1):68-88
  Vinton CL et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 62
• 文献情報：
  Scurt FG et al. Systemic Inflammation Precedes Microalbuminuria in Diabetes. Kidney Int Rep 2019 Oct;4(10):1373-1386
  Scurt FG et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 63
• 文献情報：
  Gutmann C et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun 2021 06;12(1):3406
  Gutmann C et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 64
• 文献情報：
  Bourron O et al. Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study. Cardiovasc Diabetol 2020 09;1
  Bourron O et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 65
• 文献情報：
  Jabaudon M et al. Changes in Plasma Soluble Receptor for Advanced Glycation End-Products Are Associated with Survival in Patients with Acute Respiratory Distress Syndrome. J Clin Med 2021 May;10(10)
  Jabaudon M et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 66
• 文献情報：
  Kinjo T et al. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients. Sci Rep 2020 07;10(1):12811
  Kinjo T et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 67
• 文献情報：
  Zhou X et al. Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer. BMC Endocr Disord 2020 Nov;20(1):170
  Zhou X et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 68
• 文献情報：
  Swami P et al. RAGE Up-Regulation Differently Affects Cell Proliferation and Migration in Pancreatic Cancer Cells. Int J Mol Sci 2020 Oct;21(20)
  Swami P et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 69
• 文献情報：
  Kor巽a E et al. Circulating antibodies against age-modified proteins in patients with coronary atherosclerosis. Sci Rep 2020 10;10(1):17105
  Kor巽a E et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 70
• 文献情報：
  Lazzari TK et al. Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients. PLoS One 2021;16(7):e0254198
  Lazzari TK et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 71
• 文献情報：
  C RC et al. G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer&#39;s disease pathology. PLoS One 2020;15(10):e0225487
  C RC et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：